Oral News and Research

RSS

Rochester scientists identify stem cells capable of skull formation, craniofacial bone repair in mice

A team of Rochester scientists has, for the first time, identified and isolated a stem cell population capable of skull formation and craniofacial bone repair in mice--achieving an important step toward using stem cells for bone reconstruction of the face and head in the future, according to a new paper in Nature Communications.

1 Feb 2016

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

HUYA Bioscience International President, CEO, Executive Chairman & Founder Dr. Mireille Gillings announced that Eisai Co., Ltd. has acquired from HUYA an exclusive license agreement for HBI-8000 in Japan, South Korea, Thailand, Malaysia, Indonesia, Philippines, Vietnam and Singapore.

1 Feb 2016

EC approves expanded use of Daklinza (daclatasvir) for patients with chronic HCV and HIV co-infection

Bristol-Myers Squibb today announced that the European Commission has approved the expanded use of Daklinza, a first-in-class oral, once-a-day pill used in combination with other treatments as an option for adult patients with chronic hepatitis C virus infection who are co-infected with HIV or who have had a prior liver transplant.

30 Jan 2016

Access for new melanoma treatment remains uncertain for patients despite UK launch

Novartis announced today that Tafinlar (dabrafenib) + Mekinist (trametinib), the first oral combination therapy to be licensed for advanced melanoma, is now available in the UK for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 mutation.

29 Jan 2016

Smartphone app helps increase contraceptive use among married rural women in India

A smartphone app containing motivational videos developed to help married rural women in India better understand contraceptive choices led to a dramatic increase in the number of women using modern family planning methods in just a few months, new Johns Hopkins Center for Communication Programs (CCP) research suggests.

29 Jan 2016

New blood clotting analysis system could help determine effects antithrombotic (anti-clotting) drugs

A new blood clotting analysis system designed in Japan makes it easier to determine the effects of taking one or more antithrombotic (anti-clotting) drugs.

29 Jan 2016

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

The U.S. Food and Drug Administration today approved Zepatier (elbasvir and grazoprevir) with or without ribavirin for the treatment of chronic hepatitis C virus (HCV) genotypes 1 and 4 infections in adult patients.

29 Jan 2016

Wearing glasses could significantly improve reading speed for children with severe astigmatism

For children with severe astigmatism, wearing glasses to correct blurred vision can significantly improve accurate reading speed, reports a study in the February issue of Optometry and Vision Science, official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

28 Jan 2016

10 million of us lack sunshine vitamin

Health pioneers BetterYou have welcomed the views of Nutritionist Marilyn Glenville, that ‘oil based supplements can help you get your recommended dose of vitamin D’.

From BetterYou Ltd 27 Jan 2016

Magnesium Flakes named ‘Best Sports’ product

A pioneering mineral bath soak has scooped the ‘Best Sports’ product accolade at the Natural Lifestyle Product Awards 2015.

From BetterYou Ltd 25 Jan 2016

Beta- and gamma-HPVs associated with development of head and neck cancers, finds Einstein study

Researchers at Albert Einstein College of Medicine have found that when human papillomavirus (HPV)-16 is detected in peoples' mouths, they are 22 times more likely than those without HPV-16 to develop a type of head and neck cancer.

22 Jan 2016

New interprofessional program aims to provide primary care and dental services to older adults

Primary care within a dental practice? It's an interdisciplinary idea that has teeth: Your mouth, noted the U.S. surgeon general in the Oral Health in America report, provides a window into your overall health. Now, a research team led by Maria Dolce, an associate professor in the School of Nursing at Northeastern, will make that idea a reality.

22 Jan 2016

Oral drug ivacaftor appears to be safe, beneficial to pre-school children with specific type of cystic fibrosis

The oral drug ivacaftor appears to be safe and could be beneficial to young children between the ages of 2 and 5 with a specific type of cystic fibrosis, according to new research published in The Lancet Respiratory Medicine journal.

22 Jan 2016

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Allergan plc announced today the publication of the positive results of the Phase III trials of VIBERZITM C IV (eluxadoline) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in the January 21 issue of The New England Journal of Medicine.

21 Jan 2016

Oral News and Research

Rochester scientists identify stem cells capable of skull formation, craniofacial bone repair in mice

HUYA, Eisai sign exclusive license agreement for HBI-8000 in Japan and other Asian countries

EC approves expanded use of Daklinza (daclatasvir) for patients with chronic HCV and HIV co-infection

Access for new melanoma treatment remains uncertain for patients despite UK launch

Smartphone app helps increase contraceptive use among married rural women in India

New blood clotting analysis system could help determine effects antithrombotic (anti-clotting) drugs

Zepatier receives FDA approval for treatment of chronic HCV genotypes 1 and 4 infections

Wearing glasses could significantly improve reading speed for children with severe astigmatism

10 million of us lack sunshine vitamin

Magnesium Flakes named ‘Best Sports’ product

Beta- and gamma-HPVs associated with development of head and neck cancers, finds Einstein study

New interprofessional program aims to provide primary care and dental services to older adults

Oral drug ivacaftor appears to be safe, beneficial to pre-school children with specific type of cystic fibrosis

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Combining nanomedicine with two anticancer treatments could improve outcomes for pancreatic cancer patients

Selexipag reduces clinical events in PAH patients

Weight loss may mark rapid Parkinson’s disease progression

Specialized oral nutrition supplement associated with 50% lower death rate in older patients

Oral drug rivastigmine could help prevent falls in people with Parkinson’s

Help beat the blues this Monday with a B12 Boost

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News